Catalyst Australia - English - Department of Health (Therapeutic Goods Administration)

catalyst

mannatech australia pty ltd - pyridoxine hydrochloride, quantity: 2 mg (equivalent: pyridoxine, qty 1.65 mg); nicotinamide, quantity: 5 mg; cyanocobalamin, quantity: 6 microgram; manganese amino acid chelate, quantity: 5 mg (equivalent: manganese, qty 500 microgram); calcium pantothenate, quantity: 10.92 mg (equivalent: pantothenic acid, qty 9.99 mg; equivalent: calcium, qty 916 microgram); ascorbic acid, quantity: 89.5 mg; colecalciferol, quantity: 0.0055 mg; d-alpha-tocopheryl acid succinate, quantity: 4.128 mg (equivalent: d-alpha-to - tablet, film coated - excipient ingredients: pisum sativum; microcrystalline cellulose; ethylcellulose; citrus reticulata; ethanol; soy protein; zingiber officinale; colloidal anhydrous silica; macrogol 400; barley leaf; magnesium stearate; croscarmellose sodium; spirulina; maltodextrin; hypromellose; rice bran; rice starch; maize starch; acacia; silicon dioxide; dl-alpha-tocopherol; sucrose; medium chain triglycerides; soya oil; ascorbyl palmitate; potable water; mixed (low-alpha type) tocopherols concentrate; gelatin - antioxidant/reduce free radicals formed in the body ; maintain/support body metabolism/metabolic rate ; maintain/support energy production ; maintain/support eye health ; maintain/support healthy growth and development ; maintain/support general health and wellbeing ; maintain/support healthy body tissues ; maintain/support bone strength ; maintain/support gastrointestinal system health ; maintain/support healthy immune system function ; maintain/support (state vitamin/mineral/nutrient) levels in the body ; maintain/support nervous system health

VERAPAMIL HYDROCHLORIDE- verapamil hydrochloride capsule, delayed release pellets United States - English - NLM (National Library of Medicine)

verapamil hydrochloride- verapamil hydrochloride capsule, delayed release pellets

bryant ranch prepack - verapamil hydrochloride (unii: v3888oey5r) (verapamil - unii:cj0o37ku29) - verapamil hydrochloride 360 mg - verapamil hydrochloride sustained-release capsules are indicated for the management of essential hypertension. verapamil hcl is contraindicated in: - severe left ventricular dysfunction. (see warnings. ) - hypotension (less than 90 mm hg systolic pressure) or cardiogenic shock. - sick sinus syndrome (except in patients with a functioning artificial ventricular pacemaker). - second- or third-degree av block (except in patients with a functioning artificial ventricular pacemaker). - patients with atrial flutter or atrial fibrillation and an accessory bypass tract (e.g., wolff-parkinson-white, lown-ganong-levine syndromes). (see warnings. ) - patients with known hypersensitivity to erapamil hydrochloride.

VERAPAMIL HYDROCHLORIDE tablet, film coated, extended release United States - English - NLM (National Library of Medicine)

verapamil hydrochloride tablet, film coated, extended release

state of florida doh central pharmacy - verapamil hydrochloride (unii: v3888oey5r) (verapamil - unii:cj0o37ku29) - verapamil hydrochloride 120 mg - verapamil hydrochloride extended-release tablets usp are indicated for the management of essential hypertension. verapamil hydrochloride is contraindicated in:

VERAPAMIL HYDROCHLORIDE tablet, extended release United States - English - NLM (National Library of Medicine)

verapamil hydrochloride tablet, extended release

cadila pharmaceuticals limited - verapamil hydrochloride (unii: v3888oey5r) (verapamil - unii:cj0o37ku29) - verapamil hydrochloride 180 mg - verapamil hydrochloride extended-release tablets is indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including this drug. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program's joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of pharmacolog

VERAPAMIL HYDROCHLORIDE tablet, film coated, extended release United States - English - NLM (National Library of Medicine)

verapamil hydrochloride tablet, film coated, extended release

proficient rx lp - verapamil hydrochloride (unii: v3888oey5r) (verapamil - unii:cj0o37ku29) - verapamil hydrochloride 120 mg - verapamil hydrochloride extended-release tablets usp are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including this drug. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of pharma

VERAPAMIL HYDROCHLORIDE tablet, film coated, extended release United States - English - NLM (National Library of Medicine)

verapamil hydrochloride tablet, film coated, extended release

nucare pharmaceuticals, inc. - verapamil hydrochloride (unii: v3888oey5r) (verapamil - unii:cj0o37ku29) - verapamil hydrochloride 180 mg - verapamil hydrochloride extended-release tablets are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including this drug. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of pharmacolo

VERAPAMIL HYDROCHLORIDE tablet, film coated, extended release United States - English - NLM (National Library of Medicine)

verapamil hydrochloride tablet, film coated, extended release

lake erie medical dba quality care products llc - verapamil hydrochloride (unii: v3888oey5r) (verapamil - unii:cj0o37ku29) - verapamil hydrochloride 180 mg - verapamil hydrochloride extended-release tablets usp are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including this drug. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of pharma

VERAPAMIL HYDROCHLORIDE capsule, delayed release pellets United States - English - NLM (National Library of Medicine)

verapamil hydrochloride capsule, delayed release pellets

teva pharmaceuticals inc - verapamil hydrochloride (unii: v3888oey5r) (verapamil - unii:cj0o37ku29) - verapamil hydrochloride 120 mg - verapamil hydrochloride sustained-release capsules are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including this drug. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of pharmacolo

VERAPAMIL HYDROCHLORIDE capsule, extended release United States - English - NLM (National Library of Medicine)

verapamil hydrochloride capsule, extended release

mylan pharmaceuticals inc. - verapamil hydrochloride (unii: v3888oey5r) (verapamil - unii:cj0o37ku29) - verapamil hydrochloride 120 mg - verapamil hydrochloride extended-release capsules are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including this drug. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of pharmacol

VERAPAMIL HYDROCHLORIDE capsule, extended release United States - English - NLM (National Library of Medicine)

verapamil hydrochloride capsule, extended release

lannett company, inc. - verapamil hydrochloride (unii: v3888oey5r) (verapamil - unii:cj0o37ku29) - verapamil hydrochloride 100 mg - verapamil hydrochloride extended-release capsules (pm) for oral use is indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including this drug. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program's joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a var